Sitagliptin
Sitagliptin Adamed contains the active substance sitagliptin, which belongs to a group of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which lower blood sugar levels in adults with type 2 diabetes.
This medicine helps increase the amount of insulin produced after a meal and also lowers the amount of sugar produced by the body.
Your doctor has prescribed this medicine to help lower your blood sugar levels, which are high because of your type 2 diabetes. This medicine can be used alone or in combination with other medicines that lower blood sugar levels (insulin, metformin, sulfonylurea derivatives, or glitazone), which you may already be taking for your diabetes, along with diet and exercise.
What is type 2 diabetes?
Type 2 diabetes is a condition where the body does not produce enough insulin, and the insulin produced does not work as well as it should. The body may also produce too much sugar. This can lead to serious health problems, such as heart disease, kidney disease, loss of vision, and amputation of limbs.
In patients taking sitagliptin, cases of pancreatitis (inflammation of the pancreas) have been observed (see section 4).
The appearance of blisters on the skin may be a sign of a disease called bullous pemphigoid.
Your doctor may advise you to stop taking Sitagliptin Adamed.
You should tell your doctor if you have or have had:
Children and adolescents under 18 years of age should not take this medicine.
This medicine is not effective in children and adolescents aged 10 to 17 years. It is not known whether this medicine is safe and effective when used in children under 10 years of age.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
In particular, tell your doctor if you are taking digoxin (a medicine used to treat irregular heartbeat and other heart problems). Your doctor may need to check the level of digoxin in your blood if you are taking it with Sitagliptin Adamed.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine should not be used during pregnancy.
It is not known whether this medicine passes into breast milk. This medicine should not be used if you are breastfeeding or plan to breastfeed.
This medicine has no or negligible influence on the ability to drive and use machines. However, dizziness and drowsiness have been observed, which may affect the ability to drive and use machines.
Taking this medicine in combination with medicines such as sulfonylurea and insulin may cause low blood sugar levels (hypoglycemia), which may affect the ability to drive and use machines or work without a safe support for your feet.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially 'sodium-free'.
Always take this medicine exactly as your doctor has told you.
If you are not sure, ask your doctor or pharmacist.
The usual recommended dose is:
Your doctor may prescribe this medicine alone or in combination with other medicines that lower blood sugar levels.
Diet and exercise can help your body make better use of sugar. While taking Sitagliptin Adamed, it is important to continue with the diet and exercise plan recommended by your doctor.
If you take more of this medicine than you should, contact your doctor immediately.
If you miss a dose, take it as soon as you remember. However, if you do not remember until it is time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose of this medicine.
Take this medicine for as long as your doctor recommends, so you can keep your blood sugar levels under control. Do not stop taking this medicine without talking to your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Sitagliptin Adamed and contact your doctor immediately if you experience any of the following serious side effects:
If you experience a severe allergic reaction (frequency not known), including rash, hives, blisters on the skin/peeling of the skin, and swelling of the face, lips, tongue, and throat, which may cause difficulty breathing and swallowing, stop taking this medicine and contact your doctor immediately. Your doctor may prescribe a medicine to treat the allergic reaction and another medicine to treat your diabetes.
In some patients, the following side effects have been reported after adding sitagliptin to metformin treatment:
Common (may affect up to 1 in 10 people): low blood sugar levels, nausea, bloating, vomiting
Uncommon (may affect up to 1 in 100 people): stomach pain, diarrhea, constipation, drowsiness
In some patients, the following side effects have been reported after taking sitagliptin in combination with sulfonylurea and metformin:
Very common (may affect more than 1 in 10 people): low blood sugar levels
Common: constipation
In some patients, the following side effects have been reported after taking sitagliptin and pioglitazone:
Common: bloating, swelling of the hands or feet
In some patients, the following side effects have been reported after taking sitagliptin in combination with pioglitazone and metformin:
Common: swelling of the hands or feet
In some patients, the following side effects have been reported after taking sitagliptin in combination with insulin (with or without metformin):
Common: flu
Uncommon: dry mouth
In some patients, the following side effects have been reported after taking sitagliptin alone or in combination with other anti-diabetic medicines during clinical trials or after the medicine was marketed:
Common: low blood sugar levels, headache, upper respiratory tract infection, stuffy or runny nose and sore throat, osteoarthritis, pain in the upper or lower limbs
Uncommon: dizziness, constipation, itching
Rare: decreased blood platelet count
Frequency not known: kidney problems (sometimes requiring dialysis), vomiting, stomach pain, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of blistering skin condition).
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after 'EXP'. The expiry date refers to the last day of the month.
There are no special storage requirements for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
25 mg tablet: orange, round, biconvex film-coated tablet with '25' engraved on one side.
50 mg tablet: orange, round, biconvex film-coated tablet with '50' engraved on one side.
100 mg tablet: orange, round, biconvex film-coated tablet with '100' engraved on one side.
Blisters (PVC/PVDC/Aluminium)
Pack sizes: 28, 98 film-coated tablets in blisters, packed in a cardboard box.
Not all pack sizes may be marketed.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Adamed Pharma S.A.
ul. Marszałka Józefa Piłsudskiego 5
95-200 Pabianice
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.